 CHARLOTTESVILLE, VA ACCESSWIRE January 11, 2021 Adial Pharmaceuticals, Inc. NASDAQ:ADIL; ADILW Adial or the Company, a clinical-stage biopharmaceutical company focused on the development of treatments for addictions, today announced that William Stilley, Chief Executive Officer of Adial Pharmaceuticals has been invited to present a Company overview at the 23rd Annual ICR Conference on Thursday, January 14, 2021 at 3:15pm-3:55pm Eastern Time. A live webcast of the Companys presentation will be available on the Investors section of the Companys website 